Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway

다국어 초록 (Multilingual Abstract)

Background/Aims: Patients with advanced hepatocellular carcinoma (HCC) have a poor prognosis due to the lack of effective systemic therapies. Epithelial-to-mesenchymal transition (EMT) is a pivotal event in tumor progression, during which cancer cells acquire invasive properties. In this study, we investigated the effects of phosphatidylinositol 3-kinase (PI3K) inhibitors, including LY294002 and idelalisib, on the EMT features of HCC cells in vitro.
Methods: Human HCC cell lines, including Huh-BAT and HepG2, were used in this study. Cell proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, and cell cycle distributions were evaluated using a flow cytometer by propidium iodide staining. Immunofluorescence staining, quantitative real-time polymerase chain reaction, and immunoblotting were performed to detect EMT-associated changes.
Results: PI3K inhibitors suppressed the proliferation and invasion of HCC cells and deregulated the expression of EMT markers, as indicated by increased expression of E-cadherin, an epithelial marker, and decreased expression of N-cadherin, a mesenchymal marker, and Snail, a transcription factor implicated in EMT regulation. Furthermore, LY294002 and idelalisib inhibited the phosphorylation of GSK-3β and induced the nuclear translocation of GSK-3β, which corresponded to the downregulation of Snail and β-catenin expressions in Huh-BAT and HepG2 cells.
Conclusions: The inhibition of PI3K/Akt signaling decreases Snail expression by enhancing the nuclear translocation of GSK-3β, which suppresses EMT in HCC cells, suggesting the potential clinical application of PI3K inhibitors for HCC treatment.

참고문헌 (Reference)

1 Xu Q, "α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathwa" 2014 : 546353-, 2014

2 Bautista SJ, "mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β" 293 : 14723-14739, 2018

3 Aberle H, "beta-catenin is a target for the ubiquitin-proteasome pathway" 16 : 3797-3804, 1997

4 Batlle E, "The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells" 2 : 84-89, 2000

5 Cano A, "The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression" 2 : 76-83, 2000

6 Nieto MA, "The snail superfamily of zinc-finger transcription factors" 3 : 155-166, 2002

7 Grille SJ, "The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines" 63 : 2172-2178, 2003

8 Kalluri R, "The basics of epithelial-mesenchymal transition" 119 : 1420-1428, 2009

9 Peinado H, "Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?" 7 : 415-428, 2007

10 Henderson V, "Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression" 9 : 255-264, 2015

11 Wu Y, "Snail : more than EMT" 4 : 199-203, 2010

12 McCubrey JA, "Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells" 8 : 14221-14250, 2017

13 He L, "Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin" 116 : 19523-19529, 2019

14 Han Z, "Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax" 26 : 261-268, 2007

15 Bakin AV, "Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration" 275 : 36803-36810, 2000

16 Zawel L, "P3Kα : a driver of tumor metastasis?" 1 : 315-316, 2010

17 Wiechens N, "Nucleocytoplasmic shuttling of Axin, a negative regulator of the Wnt-betacatenin Pathway" 279 : 5263-5267, 2004

18 Cong F, "Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin" 101 : 2882-2887, 2004

19 Ahn SY, "Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction" 8 : 31842-31855, 2017

20 Huang L, "MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin" 65 : 10413-10422, 2005

21 Ferenci P, "Hepatocellular carcinoma(HCC) : a global perspective" 44 : 239-245, 2010

22 Thomas MB, "Hepatocellular carcinoma : the need for progress" 23 : 2892-2899, 2005

23 Burger JA, "Haematological cancer : idelalisib-targeting PI3Kδ in patients with B-cell malignancies" 11 : 184-186, 2014

24 Dong C, "G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer" 122 : 1469-1486, 2012

25 Morgan RG, "Factors affecting the nuclear localization of β-catenin in normal and malignant tissue" 115 : 1351-1361, 2014

26 Thiery JP, "Epithelial-mesenchymal transitions in development and disease" 139 : 871-890, 2009

27 Larue L, "Epithelial-mesenchymal transition in development and cancer : role of phosphatidylinositol 3’ kinase/AKT pathways" 24 : 7443-7454, 2005

28 Zhou BP, "Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition" 6 : 931-940, 2004

29 Osakada F, "Drug development targeting the glycogen synthase kinase-3beta(GSK-3beta)-mediated signal transduction pathway : targeting the Wnt pathway and transplantation therapy as strategies for retinal repair" 109 : 168-173, 2009

30 Taylor JR, "Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells" 2 : 610-626, 2011

31 Siegel R, "Cancer statistics, 2013" 63 : 11-30, 2013

32 Castillo JJ, "CAL-101 : a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies" 21 : 15-22, 2012

33 Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method" 25 : 402-408, 2001

34 Kunter I, "Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma" 31 : 573-580, 2014

35 Xu W, "A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition" 9 : 317-324, 2015

36 Prokop JW, "A method for in silico identification of SNAIL/SLUG DNA binding potentials to the E-box sequence using molecular dynamics and evolutionary conserved amino acids" 19 : 3463-3469, 2013

37 van Zijl F, "A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression" 10 : 850-860, 2011